Loading organizations...
Generali is a global insurance and asset management company based in Trieste, Italy, that provides life, property, casualty, and corporate insurance products alongside comprehensive financial services. Established with an initial share capital of 2 million florins, the publicly listed firm generates revenue through insurance policy premiums and asset management fees across individual and corporate markets in Europe, the Americas, and Asia. The organization has expanded its international footprint through strategic acquisitions and subsidiaries, taking full control of Generali CEE Holding and acquiring the Migdal group in Israel to accelerate its regional development. Additionally, the company established Genertel to pioneer direct, phone-based financial services within the Italian market, while historical leadership included early executives and shareholders like Giovanni Cristoforo Ritter de Záhony and Marco Besso. Generali was originally founded in 1831 by primary promoter Giuseppe Lazzaro Morpurgo.
Key people at Generali.
Generali was founded in 1831 by Giuseppe Lazzaro Morpurgo (Founder).
Key people at Generali.
Generali was founded in 1831 by Giuseppe Lazzaro Morpurgo (Founder).
Generali has 4 tracked investments across 4 companies. The latest tracked deal is $7.5M Other Equity in Yolo Insurance in May 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 8, 2024 | Yolo Insurance | $7.5M Other Equity | — | Arag, Banco Besio, BE The Change, Crif, IBL Banca, Intesa Sanpaolo, NET Insurance, Primo Ventures, Reale, Sara Assicurazioni, Smart Capital |
| Apr 16, 2024 | Bcomp Ltd | $39.5M Series C | David Kurmann | Claas Carsten Kohl, BMW I Ventures, Porsche Ventures, Rkkvc, Verve Ventures, Volvo Cars, Zürcher Kantonalbank |
| Feb 11, 2016 | Regentis Biomaterials | $15.0M Series D | Haisco Pharmaceutical Group | Medica Venture Partners, SCP Vitalife Partners, Technion Innovation Opportunities Fund, Technion Research And Development Foundation |
| Jan 19, 2010 | GlobeImmune | $17.5M Series E | BSI, Generali | — |